SCHEMBL28664534

SCHEMBL28664534

CC(C)(CC1CNC1)OC(N)=O

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27934254 0.86 SLC6A1 (0.43) ATM
SCHEMBL27915636 0.86 SLC6A1 (0.43) ATM
SCHEMBL27664282 0.86 SLC6A1 (0.43) ATM
SCHEMBL27680770 0.84 LMNA (0.31) LMNAHSD17B10ATM
SCHEMBL27694069 0.82 KMT2A (0.37) LMNAATM
SCHEMBL27493732 0.82 THRA (0.39) LMNAHSD17B10ATM
SCHEMBL27568926 0.82 GABRA5 (0.34) —
Methyl Alcohol SCHEMBL27528171 0.81 GABRA5 (0.33) —
Hydrochloric Acid SCHEMBL27691589 0.81 GNAI3 (0.35) —
SCHEMBL27520063 0.79 ALOX5 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108699032-B Polycyclic TLR7/8 antagonists and their use in the treatment of immune disorders 默克专利有限公司 2022-07-22 — — CN disclosed
CN-113603675-A Polycyclic TLR7/8 antagonists and their use in the treatment of immune disorders 默克专利有限公司 2021-11-05 — — CN disclosed
Send feedback